20p13 microdeletion syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:313781Q93.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

20p13 microdeletion syndrome is a rare genetic condition caused by a small missing piece (microdeletion) of genetic material on the short arm of chromosome 20, specifically at the region labeled 13 (20p13). Because this region contains several important genes, losing a copy of them can affect how the brain and body develop. Children with this syndrome typically show developmental delay, intellectual disability, and speech and language problems. Many also have distinctive facial features, which may include a broad forehead, widely spaced eyes, a flat nasal bridge, and low-set ears. Some children may experience seizures, behavioral difficulties such as autism spectrum features, and problems with muscle tone (either too floppy or too stiff). Growth may also be affected, with some children being smaller than expected for their age. Because this is an extremely rare condition, the full range of symptoms can vary widely from person to person depending on the exact size and location of the deleted segment. There is currently no cure for 20p13 microdeletion syndrome. Treatment focuses on managing individual symptoms and supporting development. This may include speech therapy, occupational therapy, physical therapy, special education services, and medications to control seizures if they occur. Early intervention programs are very important to help children reach their full potential. A team of specialists typically works together to provide comprehensive care.

Also known as:

Key symptoms:

Developmental delayIntellectual disabilitySpeech and language delaysSeizures or epilepsyLow muscle tone (floppiness)Distinctive facial featuresBehavioral difficultiesAutism spectrum featuresShort stature or poor growthFeeding difficulties in infancyLearning difficultiesWidely spaced eyesBroad or prominent foreheadMotor skill delays

Clinical phenotype terms (35)— hover any for plain English
Small nailHP:0001792
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 20p13 microdeletion syndrome.

View clinical trials →

No actively recruiting trials found for 20p13 microdeletion syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 20p13 microdeletion syndrome community →

No specialists are currently listed for 20p13 microdeletion syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 20p13 microdeletion syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 20p13 microdeletion syndromeForum →

No community posts yet. Be the first to share your experience with 20p13 microdeletion syndrome.

Start the conversation →

Latest news about 20p13 microdeletion syndrome

No recent news articles for 20p13 microdeletion syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact size and location of my child's deletion, and which genes are affected?,Was this deletion inherited or did it happen for the first time in my child?,What therapies should we start right away to support my child's development?,Should my child have a brain MRI or EEG?,What should I watch for in terms of seizures, and what should I do if one occurs?,Are there any other specialists my child should see?,What is the chance of this happening again in a future pregnancy?

Common questions about 20p13 microdeletion syndrome

What is 20p13 microdeletion syndrome?

20p13 microdeletion syndrome is a rare genetic condition caused by a small missing piece (microdeletion) of genetic material on the short arm of chromosome 20, specifically at the region labeled 13 (20p13). Because this region contains several important genes, losing a copy of them can affect how the brain and body develop. Children with this syndrome typically show developmental delay, intellectual disability, and speech and language problems. Many also have distinctive facial features, which may include a broad forehead, widely spaced eyes, a flat nasal bridge, and low-set ears. Some childre

At what age does 20p13 microdeletion syndrome typically begin?

Typical onset of 20p13 microdeletion syndrome is infantile. Age of onset can vary across affected individuals.